These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12604039)

  • 1. Targeted liposomes for delivery of protein-based drugs into the cytoplasm of tumor cells.
    Mastrobattista E; Crommelin DJ; Wilschut J; Storm G
    J Liposome Res; 2002; 12(1-2):57-65. PubMed ID: 12604039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins.
    Mastrobattista E; Koning GA; van Bloois L; Filipe AC; Jiskoot W; Storm G
    J Biol Chem; 2002 Jul; 277(30):27135-43. PubMed ID: 12021269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting influenza virosomes to ovarian carcinoma cells.
    Mastrobattista E; Schoen P; Wilschut J; Crommelin DJ; Storm G
    FEBS Lett; 2001 Nov; 509(1):71-6. PubMed ID: 11734208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
    Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
    Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of murine lymphocytes by lipopolysaccharide incorporated in fusogenic, reconstituted influenza virus envelopes (virosomes).
    Dijkstra J; Bron R; Wilschut J; de Haan A; Ryan JL
    J Immunol; 1996 Aug; 157(3):1028-36. PubMed ID: 8757606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes).
    Bron R; Ortiz A; Wilschut J
    Biochemistry; 1994 Aug; 33(31):9110-7. PubMed ID: 8049214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of hygromycin B using reconstituted Sendai viral envelopes lacking hemagglutinin-neuraminidase.
    Bagai S; Sarkar DP
    FEBS Lett; 1993 Jul; 326(1-3):183-8. PubMed ID: 8391993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of reconstituted influenza virus envelopes with liposomes mediated by streptavidin/biotin interactions.
    Schoen P; Leserman L; Wilschut J
    FEBS Lett; 1996 Jul; 390(3):315-8. PubMed ID: 8706885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular delivery of siRNA mediated by fusion-active virosomes.
    Huckriede A; De Jonge J; Holtrop M; Wilschut J
    J Liposome Res; 2007; 17(1):39-47. PubMed ID: 17454402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic targeting of macromolecules using a pH-dependent fusogenic peptide in combination with cationic liposomes.
    Kobayashi S; Nakase I; Kawabata N; Yu HH; Pujals S; Imanishi M; Giralt E; Futaki S
    Bioconjug Chem; 2009 May; 20(5):953-9. PubMed ID: 19388672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives.
    Sasaki K; Kogure K; Chaki S; Nakamura Y; Moriguchi R; Hamada H; Danev R; Nagayama K; Futaki S; Harashima H
    Anal Bioanal Chem; 2008 Aug; 391(8):2717-27. PubMed ID: 18351325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes).
    Waelti ER; Glück R
    Int J Cancer; 1998 Aug; 77(5):728-33. PubMed ID: 9688306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
    Fattal E; Couvreur P; Dubernet C
    Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.
    de Jonge J; Holtrop M; Wilschut J; Huckriede A
    Gene Ther; 2006 Mar; 13(5):400-11. PubMed ID: 16267567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.
    Turk MJ; Reddy JA; Chmielewski JA; Low PS
    Biochim Biophys Acta; 2002 Feb; 1559(1):56-68. PubMed ID: 11825588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.
    Bungener L; Huckriede A; Wilschut J; Daemen T
    Biosci Rep; 2002 Apr; 22(2):323-38. PubMed ID: 12428908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
    Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
    Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
    Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
    Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.